2019-002603-17
A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine
Eli Lilly and Company·EU Clinical Trials Register
Study focus
- Disease/Condition
- Migraine
Sponsor & location
- Primary sponsor
- Eli Lilly and Company
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Pharmacokinetics (PK): Maximum Observed Drug Concentration
ICD-10 classifications
MigraineOther migraineMigraine, unspecifiedComplicated migraineHeadache
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2019-002603-17
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2019-002603-17 through Pure Global AI's free database. This phase not specified trial is sponsored by Eli Lilly and Company and is currently status unknown. The study focuses on Migraine.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.